Moore Capital Management, LP Celldex Therapeutics, Inc. Transaction History

Moore Capital Management, LP

  • $4.85 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$27.78 - $45.38 $555,794 - $907,917
20,007 Added 66.71%
50,000 $2.23 Million
Q3 2022

Nov 14, 2022
BUY
$22.7 - $37.57 $277,212 - $458,804
12,212 Added 68.68%
29,993 $843,000
Q1 2022

May 16, 2022
BUY
$27.64 - $39.32 $491,466 - $699,148
17,781 New
17,781 $606,000
Q1 2021

May 17, 2021
SELL
$16.19 - $29.91 $1.54 Million - $2.84 Million
-95,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$14.99 - $22.75 $1.42 Million - $2.16 Million
95,000 New
95,000 $1.66 Million

Others Institutions Holding CLDX

# of Institutions
199
Shares Held
65.9M
Call Options Held
1.68M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.15B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email